The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTouchstar Plc Regulatory News (TST)

Share Price Information for Touchstar Plc (TST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 87.50
Bid: 85.00
Ask: 90.00
Change: 0.00 (0.00%)
Spread: 5.00 (5.882%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 87.50
TST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Belgravium Technologies PLC

9 Jul 2014 11:15

RNS Number : 8544L
Belgravium Technologies PLC
09 July 2014
 



FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

Belgravium Technologies PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

Belgravium Technologies PLC

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEREE

(e) Date position held:

8 July 2014

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

 

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

The interests of the directors of Belgravium Technologies PLC in the ordinary shares of 5 pence each ("Ordinary Shares") are as follows:

 

J Kembery

9,211,269

9.13%

M Hardy

510,000

0.51%

M Unwin

300,000

0.30%

C Phillips

165,000

0.16%

 

WH Ireland (connected adviser to offeree) has an interest in 100,000 (0.10%) Ordinary Shares held on behalf of discretionary clients.

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

9 July 2014

Contact name:

Mike Coe

Telephone number:

0117 945 3470

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEBKLFBZDFBBBV
Date   Source Headline
30th Apr 202412:51 pmRNSAnnual Report & Notice of Annual General Meeting
17th Apr 20247:00 amRNSFinal Results
11th Mar 20247:00 amRNSTrading Update
16th Jan 20249:16 amRNSGrant of options
13th Dec 20237:00 amRNSDirector Appointment
9th Nov 202311:14 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Sep 20231:29 pmRNSInterim Results Correction
7th Sep 20237:00 amRNSInterim results
4th Aug 202311:25 amRNSHolding(s) in Company
4th Aug 20239:53 amRNSHolding(s) in Company
4th Aug 20237:00 amRNSDirector Dealing
3rd Aug 20233:36 pmRNSTransaction in Own Shares & TVR
31st Jul 20239:59 amRNSHolding(s) in Company
31st Jul 20239:55 amRNSHolding(s) in Company
21st Jun 20237:00 amRNSDividend Policy and Share Buy-Backs
22nd May 20232:54 pmRNSResult of AGM
26th Apr 20237:00 amRNSCapital Reduction
18th Apr 20237:00 amRNSFinal Results
23rd Jan 20237:00 amRNSTrading Update
8th Nov 20227:00 amRNSContract Award
3rd Oct 20229:28 amRNSGrant of options
15th Sep 20227:00 amRNSInterim Results
12th Aug 20229:12 amRNSHolding(s) in Company
26th Jul 20228:02 amRNSTrading Update
20th Jun 20223:00 pmRNSResult of AGM
26th Apr 20227:00 amRNSFinal Results
24th Jan 20227:00 amRNSFull Year Trading Update
20th Oct 202112:25 pmRNSHolding(s) in Company
13th Sep 20217:00 amRNSInterim Results
23rd Jun 20211:53 pmRNSResult of AGM
23rd Jun 20217:00 amRNSAGM Statement
18th Jun 20211:00 pmRNSAGM Update
29th Apr 20214:42 pmRNSSecond Price Monitoring Extn
29th Apr 20214:39 pmRNSPrice Monitoring Extension
22nd Apr 20217:00 amRNSPreliminary Results
13th Jan 20217:00 amRNSTrading Update
7th Sep 20207:00 amRNSInterim Results
30th Jun 202011:09 amRNSResult of AGM
30th Jun 20207:00 amRNSAGM Statement
28th May 20207:00 amRNSFinal Results
1st Apr 20207:00 amRNSUpdate on trading and impact of Coronavirus
26th Feb 20203:07 pmRNSHolding(s) in Company
13th Feb 20208:25 amRNSHolding(s) in Company
5th Feb 20207:00 amRNSTrading Update
28th Jan 202010:57 amRNSHolding(s) in Company
23rd Jan 20201:45 pmRNSHolding(s) in Company
20th Dec 20199:12 amRNSDirector/PDMR Shareholding
18th Dec 20197:00 amRNSTrading Statement
10th Sep 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.